Sage Therapeutics to Present at the Stifel 2019 Healthcare Conference
November 11 2019 - 4:30PM
Business Wire
Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company
committed to developing novel therapies with the potential to
transform the lives of people with debilitating disorders of the
brain, today announced that the Company will present at the Stifel
2019 Healthcare Conference on Tuesday, November 19, 2019, at 10:20
a.m. EST in New York, NY.
A live webcast of the presentation can be accessed on the
investor page of Sage's website at investor.sagerx.com. A replay of
the webcast will also be archived for up to 30 days on Sage's
website following the conference.
About Sage Therapeutics Sage Therapeutics is a
biopharmaceutical company committed to developing novel therapies
with the potential to transform the lives of people with
debilitating disorders of the brain. We are pursuing new pathways
with the goal of improving brain health, and our depression,
neurology and neuropsychiatry franchise programs aim to change how
brain disorders are thought about and treated. Our mission is to
make medicines that matter so people can get better, sooner. For
more information, please visit www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191111005596/en/
Investor Contact Matthew Calistri 617-914-2635
matthew.calistri@sagerx.com
Media Contact Alexis Smith 617-588-3740
alexis.smith@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Sep 2023 to Sep 2024